ABIN93814
antibody from antibodies-online
Targeting: TP63
EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN93814 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Protein P63 (TP63) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant p63 Protein (AA 1-205) N-terminal part of deltaNp63
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 4A4
- Vial size
- 5 mL
- Storage
- 4°C
Submitted references p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
p63 is a prostate basal cell marker and is required for prostate development.
Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G
The Journal of pathology 2002 Sep;198(1):100-9
The Journal of pathology 2002 Sep;198(1):100-9
p63 is a prostate basal cell marker and is required for prostate development.
Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M
The American journal of pathology 2000 Dec;157(6):1769-75
The American journal of pathology 2000 Dec;157(6):1769-75
Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.
Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H
Cell 1999 Oct 15;99(2):143-53
Cell 1999 Oct 15;99(2):143-53
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F
Molecular cell 1998 Sep;2(3):305-16
Molecular cell 1998 Sep;2(3):305-16
No comments: Submit comment
No validations: Submit validation data